Brain Cancer Clinical Trials

Brain Cancer Clinical Trials

Clinical Trials: A Phase 1 Dose Finding Study of the Safety and Pharmacokinetics of XL184 Administered Orally in Combination With Temozolomide and Radiation Therapy in the First Line Treatment of Subjects With Glioblastoma

Provides information to potential participants on the following clinical trial: A Phase 1 Dose Finding Study of the Safety and Pharmacokinetics of XL184 Administered Orally in Combination With Temozolomide and Radiation Therapy in the First Line Treatment of Subjects With Glioblastoma

Clinical Trials: NYU 05-40 PBMTC ONC-032P:High Dose Temozolomide,Thiotepa and Carboplatin With Autologous Stem Cell Rescue (ASCR) Followed by Continuation Therapy With 13-Cis-Retinoic Acid in Patients With Recurrent/Refractory Malignant Brain Tumors

Provides information to potential participants on the following clinical trial: NYU 05-40 PBMTC ONC-032P:High Dose Temozolomide,Thiotepa and Carboplatin With Autologous Stem Cell Rescue (ASCR) Followed by Continuation Therapy With 13-Cis-Retinoic Acid in Patients With Recurrent/Refractory Malignant Brain Tumors

Next post in Brain Cancer Clinical Trials